MedPath

UNIVERSITY OF FLORIDA

UNIVERSITY OF FLORIDA logo
🇺🇸United States
Ownership
Private
Established
1853-01-01
Employees
10K
Market Cap
-
Website
http://www.ufl.edu

Study of Temozolomide to Treat Newly Diagnosed Brain Metastases

Phase 2
Terminated
Conditions
Brain Metastases
Interventions
First Posted Date
2008-07-17
Last Posted Date
2012-10-01
Lead Sponsor
University of Florida
Target Recruit Count
3
Registration Number
NCT00717275
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Study of Pemetrexed to Treat Recurrent or Progressive Primary Central Nervous System Lymphoma

Phase 2
Withdrawn
Conditions
Primary Central Nervous System Lymphoma
Interventions
First Posted Date
2008-07-09
Last Posted Date
2011-09-20
Lead Sponsor
University of Florida
Registration Number
NCT00712062

Incidence of Oral Candidiasis, Prevalence of C. Dubliniensis in HIV Patients and In-vitro Azole Susceptibility

Terminated
Conditions
Candidiasis
HIV Infections
First Posted Date
2008-06-06
Last Posted Date
2015-05-08
Lead Sponsor
University of Florida
Target Recruit Count
10
Registration Number
NCT00692783
Locations
🇺🇸

Duval County Department of Health. Boulevard Comprehensive Care Center, Jacksonville, Florida, United States

Antimicrobial Susceptibility Patterns of N. Gonorrhea Isolates in an Era of Quinolone Resistance

Completed
Conditions
Gonorrhea
First Posted Date
2008-06-06
Last Posted Date
2012-03-07
Lead Sponsor
University of Florida
Target Recruit Count
60
Registration Number
NCT00692822
Locations
🇺🇸

Boulevard Comprehensive Care Center, Jacksonville, Florida, United States

Sleep Quality and Presence of Sleep Disordered Breathing

Completed
Conditions
HIV Infections
Sleep
First Posted Date
2008-06-06
Last Posted Date
2012-08-27
Lead Sponsor
University of Florida
Target Recruit Count
74
Registration Number
NCT00692965

Proton Therapy for Low and Intermediate Risk Prostate Cancer

Not Applicable
Completed
Conditions
Prostate Cancer
Interventions
Radiation: Intermediate Risk Proton Radiation
Radiation: Low Risk Proton Radiation
First Posted Date
2008-06-06
Last Posted Date
2023-09-18
Lead Sponsor
University of Florida
Target Recruit Count
228
Registration Number
NCT00693238
Locations
🇺🇸

University of Florida Proton Therapy Institute, Jacksonville, Florida, United States

Proton Therapy for Unresectable Cancer (CA) of Pancreas

Not Applicable
Completed
Conditions
Pancreatic Cancer
Interventions
Radiation: Proton radiation and chemotherapy
First Posted Date
2008-05-28
Last Posted Date
2017-08-24
Lead Sponsor
University of Florida
Target Recruit Count
13
Registration Number
NCT00685763
Locations
🇺🇸

University of Florida Proton Therapy Institute, Jacksonville, Florida, United States

Effect of Carvedilol Controlled-Release (CR) and Atenolol on Central Blood Pressure

Phase 4
Completed
Conditions
Hypertension
Interventions
First Posted Date
2008-04-30
Last Posted Date
2017-10-05
Lead Sponsor
University of Florida
Target Recruit Count
41
Registration Number
NCT00669279
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Neulasta in Type 1 Diabetes

Phase 1
Completed
Conditions
Type 1 Diabetes
Interventions
Drug: Placebo
Dietary Supplement: Mixed Meal Tolerance Test (MMTT)
Other: Blood test
Other: DNA Test
First Posted Date
2008-04-21
Last Posted Date
2015-04-09
Lead Sponsor
University of Florida
Target Recruit Count
21
Registration Number
NCT00662519
Locations
🇺🇸

University of Florida, Gainesville, Florida, United States

Pharmacokinetics and Pharmacodynamics of Fructose

Completed
Conditions
Healthy
Interventions
Other: Dr Pepper sweetened with sucrose or high fructose corn syrup
First Posted Date
2008-04-21
Last Posted Date
2012-02-16
Lead Sponsor
University of Florida
Target Recruit Count
40
Registration Number
NCT00661947
Locations
🇺🇸

University of Florida, Department of Pharmacy Practice, Center for Pharmacogenomics, Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath